eISSN: 2299-0038
ISSN: 1643-8876
Menopause Review/Przegląd Menopauzalny
Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures

SCImago Journal & Country Rank
 
5/2004
vol. 3
 
Share:
Share:
more
 
 
abstract:

Estradiol - novelty or standard in vaginal therapy?

Edyta Wlaźlak
,
Grzegorz Surkont
,
Jacek Suzin

Online publish date: 2004/10/22
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
Authors present review of articles about the use of vaginal tablets containing 25 µg of 17β-estradiol in the treatment of urogynecological complaints resulting from estrogen deficiency in peri- and postmenopausal women. Data shows that dose of 25 µg of 17β-estradiol does not have clinically significant systemic activity. Till now, if properly used, vaginal tablet containing 25 µg of 17β-estradiol does not show stimulating activity on endometrium. Authors consider that medicaments containing estradiol ad estriol are both standards in modern vaginal estrogen therapy. Vaginal tablet containing 17β-estradiol are noticed by most of the patients as more comfortable ad hygienic than vagitories and creams.
keywords:

vaginal estrogen therapy, menopause, urinary incontinence, atrophic vaginitis

Quick links
© 2021 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe